NorthWest Biotherapeutics Inc (NWBO)

[Umibe5690]

Meirluc:

Nice try but very difficult to provide a rigorous mathematical reverse engineering to demonstrate 23.1 months from the info given in the publication. As I raised in a previous post, there are quite a few issues that are left hanging.

While the blended results for M+ and M- are rather good, it really depends where you place the control stakes for the deltas. Further, LL's statement that all patients seemingly live longer appears rather disingenuous. Does this pertain to the non-crossovers as well? She could not know that. I do believe that crossovers may be living longer but without resection and a new lysate, to what extent if any is unknown. I think if LL said "On the whole" patients are living longer than otherwise expected" is a preferable statement as compared to.."All patients......."